Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tissue plasminogen activator and seizures: a clot-buster’s secret life
Robert Pawlak, Sidney Strickland
Robert Pawlak, Sidney Strickland
View: Text | PDF
Commentary

Tissue plasminogen activator and seizures: a clot-buster’s secret life

  • Text
  • PDF
Abstract

Authors

Robert Pawlak, Sidney Strickland

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The distribution of tPA and its role in the hippocampus. (a) tPA immunoh...
The distribution of tPA and its role in the hippocampus. (a) tPA immunohistochemistry (red) with superimposed scheme of synaptic input from the amygdala and the three-synaptic hippocampal neuronal circuit (yellow). tPA immunoreactivity is observed almost exclusively in the mossy fiber pathway (24), suggesting that it plays a particularly important role in conducting impulses from the mossy fibers to the Schaffer collaterals. Neuronal cell bodies are counterstained with 4,6-diamino-2-phenylindole (blue). CA1 and CA3, regions of the hippocampus; DG, dentate gyrus. (b) Schematic representation of a hippocampal synapse, showing the putative mechanism of tPA action at that site. tPA (gray) is released from the axon terminal upon neuronal depolarization, where it facilitates spreading of an impulse to the postsynaptic site by activating NMDA receptors (green). During excitotoxic challenge, excessive amounts of tPA could also activate plasminogen (blue) to trigger neuronal death by degrading laminin (11). tPA activity could be inhibited by neuroserpin (yellow), thus attenuating seizure spreading and cell death.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts